Cheryl E Ainslie-Waldman1, Woon-Puay Koh, Aizhen Jin, Khay Guan Yeoh, Feng Zhu, Renwei Wang, Jian-Min Yuan, Lesley M Butler. 1. Authors' Affiliations: Division of Epidemiology and Community Health, University of Minnesota, Minneapolis; Department of Food Science and Nutrition, University of Minnesota, Saint Paul, Minnesota; Cancer Control and Population Sciences, University of Pittsburgh Cancer Institute; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Duke-NUS Graduate Medical School Singapore, Singapore; Saw Swee Hock School of Public Health and Department of Medicine, National University of Singapore, Singapore; National Registry of Diseases Office, Health Promotion Board; and Department of Gastroenterology and Hepatology, National University Health System, Singapore.
Abstract
BACKGROUND: Despite experimental evidence showing chemopreventive effects of coffee-related compounds on gastric carcinogenesis, epidemiologic studies generally do not support coffee-gastric cancer associations. Observational data are lacking among high-risk populations with sufficient regular coffee consumption. METHODS: We examined the association between caffeinated coffee intake and gastric cancer risk in a population-based cohort that enrolled 63,257 Chinese men and women ages 45 to 74 years between 1993 and 1998 in Singapore. Incident gastric cancer cases (n = 647) were identified after a mean follow-up of 14.7 years. Biomarkers of Helicobacter pylori (H. pylori) infection were measured in a subset of gastric cancer cases with blood collected before cancer diagnosis and their matched controls. RESULTS: In the total cohort, daily versus nondaily coffee intake was associated with a statistically nonsignificant decrease in gastric cancer risk [HR = 0.85; 95% confidence interval (CI), 0.69-1.04]. In women, the inverse association strengthened and reached statistical significance (HR = 0.63; 95% CI, 0.46-0.87). In analyses restricted to never smokers and nondrinkers of alcohol, inverse associations strengthened in the total cohort (HR = 0.69; 95% CI, 0.52-0.91) and in women (HR = 0.52; 95% CI, 0.37-0.74). There was no coffee-gastric cancer risk association among men, regardless of smoking status or alcohol consumption. Similar results were observed in the nested case-control study after adjustment for H. pylori infection. CONCLUSION: Daily coffee consumption may reduce the risk of gastric cancer in high-risk populations, especially among women. IMPACT: Research aimed at identifying the compounds in coffee that may protect against gastric carcinogenesis is warranted.
BACKGROUND: Despite experimental evidence showing chemopreventive effects of coffee-related compounds on gastric carcinogenesis, epidemiologic studies generally do not support coffee-gastric cancer associations. Observational data are lacking among high-risk populations with sufficient regular coffee consumption. METHODS: We examined the association between caffeinated coffee intake and gastric cancer risk in a population-based cohort that enrolled 63,257 Chinese men and women ages 45 to 74 years between 1993 and 1998 in Singapore. Incident gastric cancer cases (n = 647) were identified after a mean follow-up of 14.7 years. Biomarkers of Helicobacter pylori (H. pylori) infection were measured in a subset of gastric cancer cases with blood collected before cancer diagnosis and their matched controls. RESULTS: In the total cohort, daily versus nondaily coffee intake was associated with a statistically nonsignificant decrease in gastric cancer risk [HR = 0.85; 95% confidence interval (CI), 0.69-1.04]. In women, the inverse association strengthened and reached statistical significance (HR = 0.63; 95% CI, 0.46-0.87). In analyses restricted to never smokers and nondrinkers of alcohol, inverse associations strengthened in the total cohort (HR = 0.69; 95% CI, 0.52-0.91) and in women (HR = 0.52; 95% CI, 0.37-0.74). There was no coffee-gastric cancer risk association among men, regardless of smoking status or alcohol consumption. Similar results were observed in the nested case-control study after adjustment for H. pylori infection. CONCLUSION: Daily coffee consumption may reduce the risk of gastric cancer in high-risk populations, especially among women. IMPACT: Research aimed at identifying the compounds in coffee that may protect against gastric carcinogenesis is warranted.
Authors: Eduardo De Stefani; Pelayo Correa; Paolo Boffetta; Hugo Deneo-Pellegrini; Alvaro L Ronco; María Mendilaharsu Journal: Gastric Cancer Date: 2004 Impact factor: 7.370
Authors: Y Tsubono; Y Nishino; S Komatsu; C C Hsieh; S Kanemura; I Tsuji; H Nakatsuka; A Fukao; H Satoh; S Hisamichi Journal: N Engl J Med Date: 2001-03-01 Impact factor: 91.245
Authors: Andrew O Odegaard; Mark A Pereira; Woon-Puay Koh; Kazuko Arakawa; Hin-Peng Lee; Mimi C Yu Journal: Am J Clin Nutr Date: 2008-10 Impact factor: 7.045
Authors: Nasheen Naidoo; Cynthia Chen; Salome A Rebello; Karl Speer; E Shyong Tai; Jeanette Lee; Sandra Buchmann; Isabelle Koelling-Speer; Rob M van Dam Journal: Nutr J Date: 2011-05-15 Impact factor: 3.271
Authors: Stephanie L Schmit; Hedy S Rennert; Gad Rennert; Stephen B Gruber Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-04 Impact factor: 4.254